Loading…
XWEL
XWELL, Inc.
NASDAQ· Healthcare· Diagnostics & Research· CUSIP 98420U802
$1.01+2.00%Price as of Aug 29, 18:48 UTC · updated once a day, after the close
Key metrics
- Market cap
- $8.68M
- P/E
- —
- Forward P/E
- —
- P/B
- 20.6x
- Dividend yield
- —
- Payout
- —
- EPS
- -$5.26
- ROE
- -361.36%
- Profit margin
- -82.90%
- Revenue growth
- -7.10%
- Beta
- 1.01
- 52-week high
- $2.20
- 52-week low
- $0.26
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -96.6% over 5Y.
today you would have $30.41▼ -97.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 16 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $0.46 | $1.51 | $1.74 | $7.20 | $40.40 | $23.80 | $40.20 | $192.00 | $1,644.00 | $2,556.00 | $2,964.00 | $6,600.00 | $35,520.00 | $34,440.00 | $11,880.00 | $28,560.00 | |
| P/E |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MGRXMangoceuticals Inc | $0.40 | — | 0.6x | — | -95.10% | $8.67M |
| EVGNEvogene Ltd. | $0.55 | — | — | — | -182.75% | $8.68M |
| NDRAENDRA Life Sciences Inc. | $5.80 | — | 1.4x | — | -152.04% | $8.7M |
| CODXCo-Diagnostics, Inc. | $1.21 |
About the company
XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program; and various services and support, including technical support services and advanced services. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
- 175
- New York, United States
Company description provided by Yahoo Finance.